Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2007 1
2008 5
2010 2
2011 3
2012 2
2013 1
2014 2
2015 3
2016 2
2017 8
2018 7
2019 7
2020 7
2021 6
2022 9
2023 9
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

70 results

Results by year

Filters applied: . Clear all
Page 1
Capivasertib in Hormone Receptor-Positive Advanced Breast Cancer.
Turner NC, Oliveira M, Howell SJ, Dalenc F, Cortes J, Gomez Moreno HL, Hu X, Jhaveri K, Krivorotko P, Loibl S, Morales Murillo S, Okera M, Park YH, Sohn J, Toi M, Tokunaga E, Yousef S, Zhukova L, de Bruin EC, Grinsted L, Schiavon G, Foxley A, Rugo HS; CAPItello-291 Study Group. Turner NC, et al. N Engl J Med. 2023 Jun 1;388(22):2058-2070. doi: 10.1056/NEJMoa2214131. N Engl J Med. 2023. PMID: 37256976 Clinical Trial.
Trastuzumab Deruxtecan versus Trastuzumab Emtansine for Breast Cancer.
Cortés J, Kim SB, Chung WP, Im SA, Park YH, Hegg R, Kim MH, Tseng LM, Petry V, Chung CF, Iwata H, Hamilton E, Curigliano G, Xu B, Huang CS, Kim JH, Chiu JWY, Pedrini JL, Lee C, Liu Y, Cathcart J, Bako E, Verma S, Hurvitz SA; DESTINY-Breast03 Trial Investigators. Cortés J, et al. N Engl J Med. 2022 Mar 24;386(12):1143-1154. doi: 10.1056/NEJMoa2115022. N Engl J Med. 2022. PMID: 35320644 Clinical Trial.
Personalized Systemic Therapies in Hereditary Cancer Syndromes.
Mastrodomenico L, Piombino C, Riccò B, Barbieri E, Venturelli M, Piacentini F, Dominici M, Cortesi L, Toss A. Mastrodomenico L, et al. Among authors: piacentini f. Genes (Basel). 2023 Mar 9;14(3):684. doi: 10.3390/genes14030684. Genes (Basel). 2023. PMID: 36980956 Free PMC article. Review.
Metastatic site patterns by intrinsic subtype and HER2DX in early HER2-positive breast cancer.
Dieci MV, Conte P, Bisagni G, Bartolini S, Frassoldati A, Generali D, Piacentini F, Griguolo G, Tagliafico E, Brasó Maristany F, Chic N, Paré L, Miglietta F, Vicini R, D'Amico R, Balduzzi S, Prat A, Guarneri V. Dieci MV, et al. Among authors: piacentini f. J Natl Cancer Inst. 2024 Jan 10;116(1):69-80. doi: 10.1093/jnci/djad179. J Natl Cancer Inst. 2024. PMID: 37676829 Free PMC article.
Tumor Stroma Manipulation By MSC.
Grisendi G, Spano C, Rossignoli F, D Souza N, Golinelli G, Fiori A, Horwitz EM, Guarneri V, Piacentini F, Paolucci P, Dominici M. Grisendi G, et al. Among authors: piacentini f. Curr Drug Targets. 2016;17(10):1111-26. doi: 10.2174/1389450117666160307143226. Curr Drug Targets. 2016. PMID: 26953248 Review.
Nine-Week Versus One-Year Trastuzumab for Early Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: 10-Year Update of the ShortHER Phase III Randomized Trial.
Conte P, Bisagni G, Piacentini F, Sarti S, Minichillo S, Anselmi E, Aieta M, Gebbia V, Schirone A, Musolino A, Garrone O, Beano A, Rimanti A, Giotta F, Turletti A, Miglietta F, Dieci MV, Vicini R, Balduzzi S, D'Amico R, Guarneri V. Conte P, et al. Among authors: piacentini f. J Clin Oncol. 2023 Nov 10;41(32):4976-4981. doi: 10.1200/JCO.23.00790. Epub 2023 Sep 25. J Clin Oncol. 2023. PMID: 37748109 Free PMC article. Clinical Trial.
Carcinoid Crisis: A Misunderstood and Unrecognized Oncological Emergency.
Bardasi C, Benatti S, Luppi G, Garajovà I, Piacentini F, Dominici M, Gelsomino F. Bardasi C, et al. Among authors: piacentini f. Cancers (Basel). 2022 Jan 28;14(3):662. doi: 10.3390/cancers14030662. Cancers (Basel). 2022. PMID: 35158931 Free PMC article. Review.
The Role of Exosomes in Breast Cancer Diagnosis.
Piombino C, Mastrolia I, Omarini C, Candini O, Dominici M, Piacentini F, Toss A. Piombino C, et al. Among authors: piacentini f. Biomedicines. 2021 Mar 18;9(3):312. doi: 10.3390/biomedicines9030312. Biomedicines. 2021. PMID: 33803776 Free PMC article. Review.
Ocular Toxicity in Breast Cancer Management: Manual for The Oncologist.
Canino F, Omarini C, Cerma K, Moscetti L, Tornincasa A, Trudu L, Dominici M, Piacentini F. Canino F, et al. Among authors: piacentini f. Clin Breast Cancer. 2022 Jun;22(4):289-299. doi: 10.1016/j.clbc.2022.02.002. Epub 2022 Feb 7. Clin Breast Cancer. 2022. PMID: 35246390 Review.
70 results